Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis.

Hernández-Vargas H, Palacios J, Moreno-Bueno G.

Oncogene. 2007 May 3;26(20):2902-13. Epub 2006 Nov 13.

PMID:
17099726
2.

Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses.

Bayet-Robert M, Morvan D, Chollet P, Barthomeuf C.

Breast Cancer Res Treat. 2010 Apr;120(3):613-26. doi: 10.1007/s10549-009-0430-1. Epub 2009 Jun 10.

PMID:
19513827
3.

Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells.

Morse DL, Gray H, Payne CM, Gillies RJ.

Mol Cancer Ther. 2005 Oct;4(10):1495-504.

4.

XRP6258-induced gene expression patterns in head and neck cancer carcinoma.

Yoo GH, Kafri Z, Ensley JF, Lonardo F, Kim H, Folbe AJ, Won J, Stevens T, Lin HS.

Laryngoscope. 2010 Jun;120(6):1114-9. doi: 10.1002/lary.20559.

PMID:
20513026
5.

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.

Gil EY, Jo UH, Jeong H, Whang YM, Woo OH, Cho KR, Seo JH, Kim A, Lee ES, Koh I, Kim YH, Park KH.

Int J Oncol. 2012 Aug;41(2):611-20. doi: 10.3892/ijo.2012.1470. Epub 2012 May 10.

PMID:
22581300
6.
7.

RPN2 gene confers docetaxel resistance in breast cancer.

Honma K, Iwao-Koizumi K, Takeshita F, Yamamoto Y, Yoshida T, Nishio K, Nagahara S, Kato K, Ochiya T.

Nat Med. 2008 Sep;14(9):939-48. doi: 10.1038/nm.1858. Erratum in: Nat Med. 2008 Oct;14(10):1128.

PMID:
18724378
8.

Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.

Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH.

Cell Biochem Biophys. 2009;55(2):95-105. doi: 10.1007/s12013-009-9058-3. Epub 2009 Jul 11.

PMID:
19593673
9.

Novel hydrophilic docetaxel (CQMU-0519) analogue inhibits proliferation and induces apoptosis in human A549 lung, SKVO3 ovarian and MCF7 breast carcinoma cell lines.

Fauzee NJ, Wang YL, Dong Z, Li QG, Wang T, Mandarry MT, Xu L, Pan J.

Cell Prolif. 2012 Aug;45(4):352-64. doi: 10.1111/j.1365-2184.2012.00825.x. Epub 2012 Jun 5.

PMID:
22672263
10.

Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.

Ooe A, Kato K, Noguchi S.

Breast Cancer Res Treat. 2007 Mar;101(3):305-15. Epub 2006 Jul 5.

PMID:
16821082
11.

Antitumor activity of YM155, a selective small-molecule survivin suppressant, alone and in combination with docetaxel in human malignant melanoma models.

Yamanaka K, Nakahara T, Yamauchi T, Kita A, Takeuchi M, Kiyonaga F, Kaneko N, Sasamata M.

Clin Cancer Res. 2011 Aug 15;17(16):5423-31. doi: 10.1158/1078-0432.CCR-10-3410. Epub 2011 Jul 7.

12.

miRNA-34a is associated with docetaxel resistance in human breast cancer cells.

Kastl L, Brown I, Schofield AC.

Breast Cancer Res Treat. 2012 Jan;131(2):445-54. doi: 10.1007/s10549-011-1424-3. Epub 2011 Mar 12.

PMID:
21399894
13.
14.

Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells.

Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z, Ran Y.

Oncol Rep. 2010 Jul;24(1):105-12.

PMID:
20514450
15.

Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.

Yu YN, Yip GW, Tan PH, Thike AA, Matsumoto K, Tsujimoto M, Bay BH.

Int J Oncol. 2010 Aug;37(2):483-92.

PMID:
20596676
17.

The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.

Munkarah AR, Ali-Fehmi R, Jiang JZ, Elhammady E, Malone JM Jr, Saed GM.

Anticancer Drugs. 2007 Sep;18(8):889-96.

PMID:
17667594
18.

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.

Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.

Breast Cancer Res. 2001;3(4):253-63. Epub 2001 Apr 2.

19.

Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.

Wang Z, Goulet R 3rd, Stanton KJ, Sadaria M, Nakshatri H.

Anticancer Res. 2005 May-Jun;25(3c):2367-79.

20.

Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells.

Fabbri F, Amadori D, Carloni S, Brigliadori G, Tesei A, Ulivi P, Rosetti M, Vannini I, Arienti C, Zoli W, Silvestrini R.

J Cell Physiol. 2008 Nov;217(2):494-501. doi: 10.1002/jcp.21522.

PMID:
18615564

Supplemental Content

Support Center